Robert Fanger
Upcoming Federal Funding Opportunities
There are several new opportunities for funding available with applications due in the fourth quarter of 2024 including those from NIH, NINDs and NIDA.
Wyoming Training: Insightful Knowledge and Practical Skills in Technology Commercialization
We are excited to share the success of our ASCEND2.0 Technology Commercialization Workshop held on August 22, 2024, at the University of Wyoming. This full-day event was packed with hands-on assessments, market analysis, IP strategies, licensing techniques, and effective pitching—providing attendees with the essential skills and knowledge to bring their innovations to market.
ASCEND2.0 (I-RED West) Announces Call for Proposals to Boost Biomedical Innovation
The ASCEND2.0 (I-RED West) program has officially launched its 2024 Call for Proposals, inviting innovators to submit pilot projects aimed at advancing new biomedical technologies with significant commercial potential. ASCEND2.0 is dedicated to bridging the gap between NIH-funded research and real-world patient outcomes by equipping biomedical entrepreneurs with the knowledge, skills, and training needed to succeed in the competitive healthcare market.
HHS SBIR Contracts Solicitation (PHS-2025-1) is Now Available
The SBIR Contracts Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) (PHS-2025-1) has been released.
T-Neuro Pharma Announces Publication of Groundbreaking Alzheimer’s Research in Prestigious Journal
ALBUQUERQUE, New Mexico — T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative diagnostics and therapeutics for neurodegenerative diseases, announced the publication of a landmark research article in Proceedings of the National Academy of Sciences(PNAS), a peer-reviewed journal of the National Academy of Sciences. The article, “Antigen-Specific Age-Related Memory CD8 T Cells Induce and Track Alzheimer’s-Like Neurodegeneration,” details a significant breakthrough in understanding the early events and progression of Alzheimer’s disease.
NIH Funding Opportunity and Policy Announcements
Our Weekly Update from DRCB/NIGMS highlights important NIH funding opportunities and policy announcements for researchers, students, and staff involved in our ASCEND2.0 grant.
New Pilot Project Grants Awarded at the University of Wyoming
As part of our ASCEND2.0 initiative to Wyoming, an I-RED state, we are excited to announce that two pilot project grants have been awarded and approved for the University of Wyoming. These innovative research projects are now commencing, marking a significant step forward in their respective fields.
UNLV Innovation Day a Resounding Success
We were thrilled to have helped organize and fund the pitch competition at UNLV's first-ever Innovation Day, supported by our ASCEND2.0 NIH grant. The event showcased the UNLV community's innovative ideas and entrepreneurial spirit, attracting around 70 enthusiastic attendees.
Visionary Leadership Driving Innovation at UNLV
Building on the success of UNLV's first-ever Innovation Day, we are excited to share the visionary leadership driving this initiative forward. Dr. Kate Zhong and Dr. Jeffrey Cummings have been instrumental in bringing this event to life and have ambitious plans to make it an annual tradition.
ASCEND2.0 Announces Call for Proposals: $15,000 Funding Opportunity for Biomedical Innovations
ASCEND2.0 has officially opened its call for proposals to support the advancement of new biomedical innovations with significant potential to improve quality of life and save lives.